postoperative radiotherapy in non small cell lung cancer
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot
Ngày tải lên :
18/06/2014, 16:20
... now being exploited in cancer, attempting to modulate their expression, reintroducing microRNAs lost in cancer, or inhibiting oncogenic microRNAs by using anti-micro oligonucleotides [38] In a ... Al-Saad S, Al-Shibli K, et al: Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer Clin Cancer Res 2007, 13:6649-57 World ... lymphocyte infiltration in non- small cell lung cancer Clin Cancer Res 2008, 14:5220-7 Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts of hypoxic markers according to NSCLC...
- 9
- 662
- 0
Báo cáo khoa học: " Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer" potx
Ngày tải lên :
09/08/2014, 09:22
... Jeremic B: Report from the international atomic energy agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non- small cell lung cancer (NSCLC) Int J Radiat Oncol Biol ... irradiation be omittd in Stage III non- small cell lung cancer? An analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy Int J Radiat Oncol Biol ... Yin Y: A randomized study of involved field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inperable stage III nonsmall cell lung cancer AM J Clin...
- 7
- 375
- 0
Báo cáo khoa học: " Evalution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC)" pptx
Ngày tải lên :
09/08/2014, 10:20
... [8] Similar findings were made for non- small- cell lung cancer (NSCLC), where a continuous tumor regression during radiotherapy was observed [9] This continuous tumor regression during radiotherapy ... non- small- cell lung cancer Int J Radiat Oncol Biol Phys 2008, 71:139-144 Siker ML, Tome WA, Mehta MP: Tumor volume changes on serial imaging with megavoltage CT for non- small- cell lung cancer during intensity-modulated ... PET-CT-based auto-contouring in non- small- cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes Int J Radiat...
- 13
- 255
- 0
báo cáo khoa học: " Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer" pdf
Ngày tải lên :
10/08/2014, 10:20
... mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non- small cell lung cancer cells in an epidermal growth factor receptor-independent manner Cancer Res 2005, 65(14):6275-81 ... Clinical Cancer Research 2011, 30:6 http://www.jeccr.com/content/30/1/6 Figure Cell viability (MTT assay) for determination of EC50 of COX-2 stimulation in non- small cell lung cancer cell lines ... Sun X, Roman J, Han S: Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1 Cancer Res 2009, 69(3):896-904 Mayoral...
- 10
- 265
- 0
báo cáo khoa học: "EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features" pptx
Ngày tải lên :
10/08/2014, 10:21
... chemokines ena-78/cxc ligand (cxcl) and interleukin-8/cxcl8 in human non- small cell lung cancer Cancer Res 2004, 64:1850-1860 Choe MS, Zhang X, Shin HJC, Shin DM, Chen Z: Interaction between epidermal ... phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non- small cell lung cancer Clin Cancer Res 2009, 15(6):2158-2165 ... gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non- small cell lung cancer...
- 8
- 434
- 0
báo cáo khoa học: " Correction: EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features" pps
Ngày tải lên :
10/08/2014, 10:21
... 90 Paracancerous tissue 14.3 P < 0.05 Reference Li Feng, Liu Yongmei, Chen Huijiao, Liao Dianying, Shen Yali, Xu Feng, Wang Jin: EGFR and COX-2 protein expression in non- small cell lung cancer ... Correction: EGFR and COX-2 protein expression in non- small cell lung cancer and the correlation with clinical features Journal of Experimental & Clinical Cancer Research 2011 30:32 ... clinical features Journal of Experimental & Clinical Cancer Research 2011, 30:27 doi:10.1186/1756-9966-30-32 Cite this article as: Li et al.: Correction: EGFR and COX-2 protein expression in non- small...
- 2
- 287
- 0
báo cáo khoa học: " Galectin-3 and cyclin D1 expression in non-small cell lung cancer" doc
Ngày tải lên :
10/08/2014, 10:21
... squamous cell carcinoma in 24 patients, adenocarcinoma in 15 patients, large cell carcinoma in patients and non- small cell lung cancer of unspecified type in patients Based on the TNM staging system: ... biomarkers in non- small cell lung cancer: a review Clin Cancer Res 2005, 11:3974-3986 16 Zhu CQ, Shih W, Ling CH, Tsao MS: Immunohistochemical markers of prognosis in non- small cell lung cancer: ... lectins in stage II nonsmall cell lung cancers In examinated group of 94 patients they showed poorer prognosis for the galectin-1 and galectin-3-expressing tumor in the univariate survival examination...
- 7
- 242
- 0
báo cáo khoa học: "Recent advances of novel targeted therapy in non-small cell lung cancer" pot
Ngày tải lên :
10/08/2014, 22:20
... cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFRexpressing advanced non- small- cell lung cancer Ann Oncol 2008 in press Pirker R, Szczesna ... apoptosis in the EGFRL858R non- small- cell lung cancer cell line H3255 Cancer Res 2004, 64:7241-7244 Shepherd FA: Molecular selection of patients for first-line treatment of advanced non- small- cell lung ... Perez-Soler R: Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non small- cell lung cancer Clin Lung Cancer 2004, 6(Suppl 1):S20-S23...
- 18
- 390
- 0
báo cáo khoa học: "Updates in non-small cell lung cancer - insights from the 2009 45th annual meeting of the American Society of Clinical Oncology" potx
Ngày tải lên :
10/08/2014, 22:21
... al.: Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non- Small- Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial J Clin Oncol 2007, 25(12):1545-1552 ... erlotinib in advanced non- small cell lung cancer (NSCLC) patients (p) with mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) J Clin Oncol (Meeting Abstracts) ... first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non- small cell lung cancer (NSCLC) in Asia (IPASS) J Clin Oncol (Meeting...
- 11
- 406
- 0
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot
Ngày tải lên :
09/08/2014, 08:23
... concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non- small- cell lung cancer J Clin Oncol 1999, 17:2692-2699 Komaki ... radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non- small- cell lung cancer (NSCLC) and an increased risk of treatment complications: Preliminary results ... pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced nonsmall cell lung cancer Clin Oncol 2002, 14:361-366 Semrau...
- 8
- 371
- 0
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps
Ngày tải lên :
09/08/2014, 09:22
... influence of different planning algorithms on the planning of stereotactic radiotherapy Therefore, an additional planning study was performed in 22 stage IA and stage 1B non- small cell lung cancer ... stereotactic body radiotherapy for stage I non- small cell lung cancer Radiother Oncol 2007, 85:429-434 Sinha B, McGarry RC: Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana ... Vedam SS, Johnson V, Chi PC, Pan T: Cine Computed Tomography Without Respiratory Surrogate in Planning Stereotactic Radiotherapy for Non- Small- Cell Lung Cancer Int J Radiat Oncol Biol Phys 2008...
- 14
- 308
- 0
Báo cáo khoa học: " Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer" pps
Ngày tải lên :
09/08/2014, 10:21
... thoracic radiotherapy in combination with mito- 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 mycin, vindesine, and cisplatin in unresectable stage III nonsmall -cell lung cancer J Clin Oncol 1999, ... Gonzalez GD, Bartelink H: Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non- small cell lung cancer Eur J Cancer 1996, 32A:1314-1319 Uitterhoeve AL, ... Methods Worldwide and in Europe lung cancer is the most common cause of cancer related-death with an increasing incidence each year The majority of patients has Non- Small Cell Lung Cancer (NSCLC) and...
- 10
- 336
- 0
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
Ngày tải lên :
18/06/2014, 16:20
... previously described [14]: = negative or faint staining in 10% of cancer cells; = moderate staining; = strong staining A score of was considered negative, ... receptor tyrosine kinases, which also includes HER2/neu, HER3, and HER4 [15] Activating mutations in the tyrosine kinase domain, involving mainly exons 19 and 21, play an important role in lung oncogenesis ... AF: Activating and resistance mutations of EGFR in non- small- cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors Oncogene 2009, 28(Suppl 1):S24-31 10 Molina-Vila MA,...
- 8
- 798
- 0
Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx
Ngày tải lên :
08/08/2014, 17:20
... versus vinorelbine or ifosfamide in patients with advanced non- small- cell lung cancer previously treated with platinum-containing chemotherapy regimens The TAX 320 Non- Small Cell Lung Cancer Study ... expression in non- small cell lung cancer Is correlated with survival Clin Cancer Res 2001; 7(7): 1850-5 93 Cappuzzo F, Gregorc V, Rossi E, et al Gefitinib in pretreated non- small- cell lung cancer ... sensitivity to gefitinib in non- small cell lung cancer cell lines Mol Cancer Res 2006; 4(8): 521-8 102.Taguchi F, Solomon B, Gregorc V, et al Mass spectrometry to classify non- small- cell lung cancer patients...
- 9
- 203
- 0
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx
Ngày tải lên :
09/08/2014, 03:21
... Docetaxel versus docetaxel/cisplatin in patients with advanced non- small- cell lung cancer: preliminary analysis of a multicenter, randomized phase III study Clin Lung Cancer 2003, 4:288-93 Lilenbaum ... Saville W, Chahinian P, Weeks JC, Holland JC, Green MR: Single-agent versus combination chemotherapy in advanced non- small- cell lung cancer: the cancer and leukemia group B (study 9730) J Clin Oncol ... response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer World Journal of Surgical Oncology 2010 8:8 Conflict of interests...
- 4
- 303
- 0
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx
Ngày tải lên :
09/08/2014, 09:20
... prediction in primary radiotherapy of non- small- cell lung cancer Int J Radiat Oncol Biol Phys 2002, 52:382-389 Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy in treatment ... failure following stereotactic body radiation therapy in earlystage non- small- cell lung cancer: clinical implications Radiother Oncol 2010, 94:1-11 Chen Y, Guo W, Lu Y, Zou B: Dose-individualized ... Cite this article as: Baba et al.: Clinical outcomes of stereotactic body radiotherapy for stage I non- small cell lung cancer using different doses depending on tumor size Radiation Oncology...
- 7
- 297
- 0
Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx
Ngày tải lên :
09/08/2014, 09:20
... Metastases in Non- Small- Cell Lung Cancer: A Systematic Review and Pooled Analysis J Clin Oncol 2008, 26:1142-1147 15 Pfannschmidt J, Dienemann H: Surgical Treatment of Oligometastatic Non- Small Cell Lung ... NSCLC to any organ(s), including brain, bone, liver, or lung were included in this study Only patients with biopsy-proven NSCLC were included Those with prior curative-intent treatment of metastatic ... Number of Metastatic Sites is a Strong Predictor of Survival in Patients with Nonsmall Cell Lung Cancer With or Without Brain Metastases Cancer 2009, 115:2930-2938 doi:10.1186/1748-717X-6-80 Cite...
- 7
- 368
- 0
Báo cáo y học: "Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer" pot
Ngày tải lên :
10/08/2014, 09:22
... clinical trials for locally advanced non- small cell lung cancer in Japan Int J Clin Oncol 2008, 13:112-6 Farray D, Mirkovic N, Albain KS: Multimodality therapy for stage III nonsmall -cell lung ... cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non- small- cell lung cancer: Four-Arm Cooperative Study in Japan ... Miyaoka E: The Japanese Joint Committee of Lung Cancer Registry Prognosis of 6644 resected non- small cell lung cancers in Japan: a Japanese lung cancer registry study Lung Cancer 2005, 50:227-34...
- 8
- 484
- 0
Báo cáo y học: "RNA interference against polo-like kinase-1 in advanced non-small cell lung cancers" doc
Ngày tải lên :
10/08/2014, 09:22
... NSCLC: non- small cell lung cancer; nt: nucleotide; PAZ: Piwi/ Argonaute/Zwille; PLK-1: Polo-like kinase-1; RISC: RNA-induced silencing complex; RNAi: RNA interference; siRNA: small interfering RNA; ... using a mouse model [62] Preclinical application of RNAi therapy against PLK-1 in a murine advanced lung cancer model Here we introduce an application of PLK-1 siRNA against an advanced lung cancer ... an N-terminal helicase domain, an RNA-binding Piwi/Argonaute/Zwille (PAZ) domain, two tandem RNAse III domains, and a dsRNA-binding domain [26,27] Mammals and nematodes have only a single Dicer,...
- 6
- 322
- 0
Báo cáo y học: "proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database" docx
Ngày tải lên :
10/08/2014, 09:22
... entered into the database Patients with non- small cell lung cancer comprise the majority of cases annotated within the database Other cancers contained in the database include small cell lung cancer, ... of indicates faint staining, indicates medium intensity staining, and indicates dark staining Furthermore, the pathologist is also able to visually assess the localization of predominant protein ... IRB: Institutional Review Board; NAACCR: North American Association of Central Cancer Registries; NCI: National Cancer Institute; Non- RTK: Non- Receptor Tyrosine Kinase; NSCLC: Non- Small Cell Lung...
- 11
- 335
- 0